Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Table of Contents

April 01, 2011; Volume 78,Issue 4

From the Editor

  • You have access
    Gene-based, rational drug-dosing: An evolving, complex opportunity
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 218; DOI: https://doi.org/10.3949/ccjm.78b.11004

    Pharmacogenomics promises the opportunity to match the right drug and dose to the right patient. We are not there yet, but the day is coming.

Medical Grand Rounds

  • You have access
    Ending LGBT invisibility in health care: The first step in ensuring equitable care
    Harvey J. Makadon, MD
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 220-224; DOI: https://doi.org/10.3949/ccjm.78gr.10006

    Lesbian, gay, bisexual, and transgender individuals experience health care disparities that will be eliminated only if clinicians elicit information in a thoughtful, nonjudgmental way.

The Clinical Picture

  • You have access
    Leukemia cutis
    Christos Tziotzios, BA, MA, MB, BChir (Cantab) and Areti Makrygeorgou, MD
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 226-227; DOI: https://doi.org/10.3949/ccjm.78a.10127

    This condition occurs in 10% to 15% of patients with acute myeloid leukemia and is a poor prognostic sign.

Im Board Review

  • You have access
    Nausea, vomiting, and panic attacks in a 50-year-old woman
    Joshua Bear, MA and Franklin A. Michota, MD
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 233-239; DOI: https://doi.org/10.3949/ccjm.78a.10082

    Six months ago she started to have panic attacks that roused her from sleep. Lately, they have become more frequent and more severe. What is the cause?

Editorial

  • You have access
    Pharmacogenomics for the primary care provider: Why should we care?
    Kathryn Teng, MD
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 241-242; DOI: https://doi.org/10.3949/ccjm.78a.11017

    Personalized medicine promises to improve the quality and lower the cost of care if physicians integrate into practice useful new findings, such as information gleaned from pharmacogenomic testing.

Review

  • Pharmacogenomic testing: Relevance in medical practice
    You have access
    Pharmacogenomic testing: Relevance in medical practice
    Joseph P. Kitzmiller, MD, PhD, David K. Groen, MD, Mitch A. Phelps, PhD and Wolfgang Sadee, Dr rer nat
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 243-257; DOI: https://doi.org/10.3949/ccjm.78a.10145

    Knowing their patients’ genetic status, physicians could predict their response to certain drugs, such as clopidogrel (Plavix), warfarin (Coumadin), tamoxifen (Nolvadex), codeine, and psychotropic medications.

  • You have access
    Managing newly diagnosed atrial fibrillation: Rate, rhythm, and risk
    Thomas Callahan, MD and Brian Baranowski, MD
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 258-264; DOI: https://doi.org/10.3949/ccjm.78a.09165

    Treatment focuses on controlling the heart rate, preventing thromboembolic events, and, depending on symptoms, restoring and maintaining sinus rhythm.

  • You have access
    Giant cell arteritis: Suspect it, treat it promptly
    Alexandra Villa-Forte, MD, MPH
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 265-270; DOI: https://doi.org/10.3949/ccjm.78a.10131

    Giant cell arteritis is the most common form of vasculitis affecting older people. Physicians should be familiar with its variety of clinical presentations.

Departments

  • You have access
    Airway pressure release ventilation (February 2011)
    Cleveland Clinic Journal of Medicine April 2011, 78 (4) 240;

    Errors in the citation of sources for figures in Modrykamien A, Chatburn RL, Ashton RW. Airway pressure release ventilation: An alternative mode of mechanical ventilation in acute respiratory distress syndrome. Cleve Clin J Med 2011; 78:101–110.

Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 78 (4)
Cleveland Clinic Journal of Medicine
Vol. 78, Issue 4
1 Apr 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • From the Editor
  • Medical Grand Rounds
  • The Clinical Picture
  • Im Board Review
  • Editorial
  • Review
  • Departments
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
The beat goes on: Highlights from the new American and European A-fib guidelines
What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
Tinea incognito
Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
Nociplastic pain: A practical guide to chronic pain management in the primary care setting
Sarcoidosis with diffuse purplish erythematous plaques on the hands
Cardiovascular disease in people living with HIV: Risk assessment and management
Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
Don’t judge a book by its cover: Unusual presentations of pericardial disease
Hypoglycemia after bariatric surgery: Management updates
Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation
Common electrolyte imbalance, uncommon cause

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire